TIFFANY BOSTWICK: Open Payments
NPI 1174077390 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 9 payments from 6 companies in 2025. Trend: 2023 $37 · 2024 $399 · 2025 $776
Consulting: $600Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $619 |
| Daiichi Sankyo Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| BeOne Medicines USA, Inc. | 1 | $18 |
| TerSera Therapeutics LLC | 1 | $16 |
Products named: ENHERTU, DATROWAY, ICLUSIG, LYNPARZA, TAGRISSO, BRUKINSA, Xermelo, INJECTAFER.
Industry payments across NC — which companies pay providers there.
